Instructions for your poster presentation

EQUITY OPTIONS
Information Circular
#06-0064 Derivative Securities
Date
January 20, 2006
To
Members, Member Organizations & Registered Option Principals
From
Gabrielle Capelli, Options Manager
Subject
New Option Listing — Bioenvision, Inc. (BQN)
The Exchange is pleased to announce that options trading will commence on Monday, January 23, 2006,
in all expiration months and strike prices, currently in the marketplace on the underlying security of:
BIOENVISION, INC.
Bioenvision, Inc. is a biopharmaceutical company primarily focused on the research and development of products and
technologies for the treatment of cancer.
Specialist Unit: Kellogg Capital Group, LLC
Post:
8
Stock symbol: BIVN
Option symbol: BQN
Position/exercise limits: 7,500,000 shares
Cycle:
March
Questions concerning this circular may be directed to the AMEX Derivative Securities Hotline: 800-THE-AMEX. Copies of this and other
Information Circulars may be accessed on the AmexTrader.com Website.
`